Federal Circuit Quashes $287 Million Enhanced Damages Award Finding Objectively Reasonable Defenses Raised During Litigation

Aug 11, 2015

Reading Time : 1 min

In Carnegie Mellon Univ. v. Marvel Tech. Grp., Ltd., a jury awarded over a billion dollars in damages after finding Marvel had infringed Carnegie Mellon’s patents. The district court added 23 percent in enhanced damages after finding willful infringement on the grounds that Marvel’s trial defenses were not objectively reasonable and that Marvel knew of should have known its actions would infringe the patents. On appeal, the Federal Circuit held Marvel had presented defenses during the litigation that were objectively reasonable.

First, the court rejected the district court’s premise that a reasonable defense had to be known to Marvel during the time prior to the litigation. Quoting In re Seagate, the court reiterated that “‘[t]he state of mind of the accused infringer is not relevant to th[e] objective inquiry’ into the risk of liability to the defendant necessary for a finding of recklessness.” Citing further precedent, the court held there is no temporal aspect to the objective reasonableness of a defense, i.e. Marvel need not have “had the defense in mind before the litigation.”

Second, the court rejected the district court’s distinction between those defenses presented at trial and those raised an earlier stage, such as during summary judgment proceedings. The court held objectively reasonable defenses can include “claim­construction arguments [and] other defense that [do] not make the cut for consuming precious time and attention of the jury. Indeed, the court noted the record of defenses as a whole must be examined, and that the “record is not limited to evidence presented to the jury.” Thus, Marvel did not have to present a defense to the jury for that defense to be found objectively reasonable.

Carnegie Mellon Univ. v. Marvel Tech. Grp., Ltd., No. 2014­1492 (Fed. Cir. Aug. 4, 2015) [Taranto (opinion), Wallach, Chen].

Share This Insight

Categories

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.